p38 MAPK regulates Th2 cytokines release in PBMCs in allergic rhinitis rats

Abstract

Th2 cytokines play a pivotal role in the pathogenesis of allergic rhinitis. To investigate the effect of p38 mitogen-activated protein kinase (MAPK) on the production of Th2 cytokines such as IL-4 and IL-5 in allergic rhinitis, a model of allergic rhinitis was established in SD rats. The expression level of p38 MAPK mRNA in PBMCs was detected by means of real time quantitative RT-PCR. The p38 MAPK activity in PBMCs was detected by Western blotting. PBMCs were cultured with various concentrations of p38 MAPK inhibitor SB 239063 or without the treatment, and then IL-4, IL-5 levels of the supernatant were determined by using sandwich ELISA. The results showed that mRNA expression and activity of p38 MAPK in PBMCs were significantly higher in allergic rhinitis rats than in control rats (P<0.05). The p38 MAPK inhibitor SB 239063 decreased the production of IL-4 and IL-5 in a dose-dependent manner. It is concluded that p38 MAPK plays an important role in the pathogenesis of allergic rhinitis which is associated with Th2 cytokines release.

Keywords

allergic rhinitis / p38 MAPK / SB 239063

References

[1] WeberR.W.. Allergic rhinitis. Prim Care, 2008, 35(1): 1-10

[2] DodellerF., SkapenkoA., KaldenJ.R., et al.. The p38 mitogen-activated protein kinase regulates effector functions of primary human CD4 T cells. Eur J Immunol, 2005, 35(12): 3631-3642

[3] DodellerF., Schulze-KoopsH.. The p38 mitogen-activated protein kinase signaling cascade in CD4 T cells. Arthritis Res Ther, 2006, 8(2): 205

[4] LivakK.J., SchmittgenT.D.. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 2001, 25(4): 402-408

[5] AdachiT., AlamR.. The mechanism of IL-5 signal transduction. Am J Physiol, 1998, 275(3Pt1): C623-633

[6] WongW.S., LeongK.P.. Tyrosine kinase inhibitors: a new approach for asthma. Biochim Biophys Acta, 2004, 1697(1–2): 53-69

[7] LiuY., ShepherdE.G., NelinL.D.. MAPK phosphatases-regulating the immune response. Nat Rev Immunol, 2007, 7(3): 202-212

[8] MoriA., KaminumaO., MiyazawaK., et al.. p38 mitogen-activated protein kinase regulates human T cell IL-5 synthesis. J Immunol, 1999, 163(9): 4763-4771

[9] KoprakS., StaruchM.J., DumontF.J.. A specific inhibitor of the p38 mitogen activated protein kinase affects differentially the production of various cytokines by activated human T cells: dependence on CD28 signaling and preferential inhibition of IL-10 production. Cell Immunol, 1999, 192(2): 87-95

[10] DuanW., ChanJ.H., McKayK., et al.. Inhaled p38alpha mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice. Am J Respir Crit Care Med, 2005, 171(6): 571-578

[11] GrossmanJ.. One airway, one disease. Chest, 1997, 111(2Suppl): 11S-16S

[12] SerranoC., ValeroA., PicadoC.. Rhinitis and asthma: one airway, one disease. Arch Bronconeumol, 2005, 41(10): 569-578

[13] UnderwoodD.C., OsbornR.R., KotzerC.J., et al.. SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. J Pharmacol Exp Ther, 2000, 293(1): 281-288

[14] IrusenE., MatthewsJ.G., TakahashiA., et al.. p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J Allergy Clin Immunol, 2002, 109(4): 649-657